Banting Labs is part of a project called Hoop Diabetes, which emerged from the need to improve the quality of life for individuals with type 1 diabetes when a close team member was diagnosed with this condition.

​

The project is the result of an extensive journey of research and development, involving technology, market research, and user knowledge.

​

Banting Labs aims to apply its real-time non-invasive continuous measurement technology to analyze and monitor biomarkers and/or molecules.

​

The initial product planned for market release is the first integrated multisensor providing real-time readings of blood glucose.